ROYCE & ASSOCIATES LP - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 31 filers reported holding AXSOME THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$1,369,000
-5.9%
20,300
-21.0%
0.01%
-10.0%
Q1 2021$1,455,000
-30.5%
25,7000.0%0.01%
-41.2%
Q4 2020$2,094,000
+14.4%
25,7000.0%0.02%
-15.0%
Q3 2020$1,831,000
-13.4%
25,7000.0%0.02%
-13.0%
Q2 2020$2,115,000
-10.3%
25,700
-35.9%
0.02%
-28.1%
Q1 2020$2,359,000
-62.0%
40,100
-33.3%
0.03%
-41.8%
Q4 2019$6,212,000
+193.2%
60,100
-42.6%
0.06%
+175.0%
Q3 2019$2,119,000
-28.3%
104,700
-8.7%
0.02%
-25.9%
Q2 2019$2,954,000
+13.8%
114,700
-37.1%
0.03%
+22.7%
Q1 2019$2,596,000
+177.1%
182,400
-45.1%
0.02%
+175.0%
Q4 2018$937,000
-18.3%
332,4000.0%0.01%0.0%
Q3 2018$1,147,000
-59.7%
332,400
-62.6%
0.01%
-60.0%
Q2 2018$2,843,000
+21.4%
888,400
-7.1%
0.02%
+25.0%
Q1 2018$2,342,000
-52.5%
956,000
+8.5%
0.02%
-51.5%
Q4 2017$4,934,000
+0.9%
881,0000.0%0.03%
+3.1%
Q3 2017$4,890,000
+0.9%
881,0000.0%0.03%0.0%
Q2 2017$4,846,000
+41.0%
881,0000.0%0.03%
+45.5%
Q1 2017$3,436,000881,0000.02%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 788,263$35,172,00044.43%
Fairmount Funds Management LLC 1,896,647$84,628,00014.88%
ACT CAPITAL MANAGEMENT, LLC 73,000$3,257,0004.50%
Ghost Tree Capital, LLC 300,000$13,386,0003.76%
Ikarian Capital, LLC 407,600$18,188,0003.62%
Paradigm Biocapital Advisors LP 520,080$23,206,0003.09%
MORGAN JESS S & CO INC 78,895$3,520,0003.06%
PFM Health Sciences, LP 1,659,733$74,057,0002.68%
RTW INVESTMENTS, LP 1,882,164$83,982,0001.94%
Ghost Tree Capital, LLC 150,000$6,693,0001.88%
View complete list of AXSOME THERAPEUTICS INC shareholders